⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MREO News
Mereo BioPharma Group plc American Depositary Shares
Pomerantz LLP Advises Shareholders of Class Action Involving Mereo BioPharma Group plc – MREO
accessnewswire.com
MREO
Levi & Korsinsky, LLP: Clinical Trial Failures and Market Reaction at Issue In Mereo BioPharma Litigation
globenewswire.com
MREO
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Mereo BioPharma Group plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – MREO
globenewswire.com
MREO
MREO INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Mereo BioPharma Group plc Shareholders Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
MREO
Pomerantz LLP Highlights Class Action Against Mereo BioPharma Group plc – MREO
accessnewswire.com
MREO
Mereo BioPharma Group plc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MREO
prnewswire.com
MREO
MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm
prnewswire.com
MREO
Pomerantz LLP Advises Shareholders of Class Action Filing Involving Mereo BioPharma Group plc – MREO
accessnewswire.com
MREO
Pomerantz LLP Calls Attention to Class Action Involving Mereo BioPharma Group plc – MREO
accessnewswire.com
MREO
MREO SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026
accessnewswire.com
MREO